Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane)

Soto, Alvaro Juarez; Gomes, Andrea Juliana Pereira de Santana; Given, Robert W.; Merseburger, Axel Stuart; Ozguroglu, Mustafa; Uemura, Hirotsugu; Ye, Dingwei; Londhe, Anil; Lopez-Gitlitz, Angela; McCarthy, Sharon Anne; Mundle, Suneel; Chi, Kim N.; Agarwal, Neeraj; Chowdhury, Simon; Bjartell, Anders; Chung, Byung Ha

dc.contributor.author	Soto, Alvaro Juarez
dc.contributor.author	Gomes, Andrea Juliana Pereira de Santana
dc.contributor.author	Given, Robert W.
dc.contributor.author	Merseburger, Axel Stuart
dc.contributor.author	Ozguroglu, Mustafa
dc.contributor.author	Uemura, Hirotsugu
dc.contributor.author	Ye, Dingwei
dc.contributor.author	Londhe, Anil
dc.contributor.author	Lopez-Gitlitz, Angela
dc.contributor.author	McCarthy, Sharon Anne
dc.contributor.author	Mundle, Suneel
dc.contributor.author	Chi, Kim N.
dc.contributor.author	Agarwal, Neeraj
dc.contributor.author	Chowdhury, Simon
dc.contributor.author	Bjartell, Anders
dc.contributor.author	Chung, Byung Ha
dc.date.accessioned	2021-03-03T17:23:28Z
dc.date.available	2021-03-03T17:23:28Z
dc.identifier.citation	Agarwal N., Chowdhury S., Bjartell A., Chung B. H. , Gomes A. J. P. d. S. , Given R. W. , Soto A. J. , Merseburger A. S. , Ozguroglu M., Uemura H., et al., "Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane)", Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38
dc.identifier.other	vv_1032021
dc.identifier.other	av_4979166c-e0cc-458e-8f77-de92a3a1a010
dc.identifier.uri	http://hdl.handle.net/20.500.12627/52850
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.subject	Tıp
dc.title	Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane)
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	38
dc.contributor.firstauthorID	2277797

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster